| Body mass index category (kg/m2) | |||
---|---|---|---|---|
Characteristics N = 817 | < 21.0 | 21.0-24.9 | ≥25.0 | P-value |
N = 216 | N = 439 | N = 162 | ||
Age (years) | 67 ± 9 | 67 ± 9 | 63 ± 9 | < 0.001 |
Body mass index (kg/m2) | 19.5 ± 1.1 | 23.0 ± 1.1 | 27.0 ± 2.0 | < 0.001 |
Alcohol consumptiona (%) | 37.0/20.8/9.3/32.9 | 42.6/21.9/9.1/26.4 | 34.6/30.2/7.4/27.8 | 0.157 |
Smoking statusb (%) | 25.5/30.6/25.9/18.1 | 25.1/27.6/26.4/21.0 | 23.5/28.4/24.7/23.5 | 0.910 |
History of CVD, N (%) | 16 (7.4) | 41 (9.3) | 11 (6.8) | 0.514 |
Systolic blood pressure (mmHg) | 132 ± 21 | 136 ± 19 | 142 ± 18 | < 0.001 |
Diastolic blood pressure (mmHg) | 79 ± 11 | 82 ± 10 | 85 ± 11 | < 0.001 |
Triglycerides (mg/dL) | 79 (59-101) | 95 (72-141) | 119 (81-161) | < 0.001 |
HDL cholesterol (mg/dL) | 67 ± 17 | 58 ± 15 | 53 ± 13 | < 0.001 |
LDL cholesterol (mg/dL) | 103 ± 28 | 114 ± 30 | 115 ± 33 | < 0.001 |
Antilipidemic medication, N (%) | 3 (1.4) | 25 (5.7) | 9 (5.6) | 0.035 |
Fasting plasma glucose (mg/dL) | 98 (91-114) | 102 (93-117) | 103 (94-120) | 0.042 |
Antiidiabetic medication, N (%) | 6 (2.8) | 28 (6.4) | 8 (4.9) | 0.145 |
Serum uric acid (mg/dL) | 5.3 ± 1.2 | 5.7 ± 1.3 | 5.9 ± 1.2 | < 0.001 |
eGFR (ml/min./1.73m2) | 79.8 ± 13.9 | 77.0 ± 14.3 | 78.6 ± 15.3 | 0.051 |
Aspartate transaminase (IU/L) | 17 (14-23) | 19 (15-25) | 23 (17-32) | < 0.001 |
γ-glutamyl transpeptidase (IU/L) | 29 (20-43) | 30 (22-49) | 44 (28-69) | < 0.001 |